WO1996029943A1 - Photodynamic therapy system and method - Google Patents

Photodynamic therapy system and method Download PDF

Info

Publication number
WO1996029943A1
WO1996029943A1 PCT/US1996/004252 US9604252W WO9629943A1 WO 1996029943 A1 WO1996029943 A1 WO 1996029943A1 US 9604252 W US9604252 W US 9604252W WO 9629943 A1 WO9629943 A1 WO 9629943A1
Authority
WO
WIPO (PCT)
Prior art keywords
radiation
transmission means
lumen
emitting portion
body lumen
Prior art date
Application number
PCT/US1996/004252
Other languages
French (fr)
Inventor
Michael Aita
Michael Buchin
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of WO1996029943A1 publication Critical patent/WO1996029943A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • A61B18/245—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22038—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with a guide wire
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22057—Optical properties
    • A61B2017/22059—Optical properties transparent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22072—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other
    • A61B2017/22074—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other the instrument being only slidable in a channel, e.g. advancing optical fibre through a channel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22072—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other
    • A61B2017/22078—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an instrument channel, e.g. for replacing one instrument by the other for rotating the instrument within a channel, e.g. an optical fibre
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
    • A61B2017/22087—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance photodynamic

Definitions

  • This invention is directed to the treatment of blood vessels affected
  • arteriosclerosis and more particularly to an assembly and method for preventing the restenosis of vessels following angioplasty comprising
  • Arteriosclerosis is a common condition which occurs when atheromas, fatty-like substances, deposit in the blood vessels of a patient. Stenoses resulting from such deposits can seriously interfere with blood flow in the affected vessel, creating ischemic conditions distal to the stenosis. Balloon angioplasty procedures are a well known means for recanalizing stenosed vessels but currently suffer from a high rate of
  • restenosis requiring additional angioplasty or resort to other treatments such as atherectomy. Further, restenosis is also associated with these other means of treating arteriosclerosis.
  • UV radiation having a wavelength of approximately 320 to 400 nm.
  • the means for diffusing radiation at the end of the fiber increases the diameter of the optical fiber and correspondingly increases the overall outer diameter of the system.
  • the means for diffusing radiation involves removing the protective sheath and cladding from a distal portion of the optical fiber, making the fiber susceptible to breakage.
  • This invention provides a method for treating a wall defining a patient's body lumen by irradiation comprising the steps of providing an elongated, flexible radiation transmission means having an emitting portion at its distal end, advancing the radiation transmission means within the patient's body lumen until the emitting portion is adjacent an area of the wall defining the body lumen to be treated by irradiation, and directing radiation through the transmission means while moving the transmission means to cause the emitting portion to irradiate a length of the wall of the body lumen.
  • the radiation transmission means is moved longitudinally within the body lumen.
  • the emitting portion of the transmission means may be configured to bias the radiation in a particular radial direction.
  • the transmission means may be rotated independently or in conjunction with longitudinal movement to achieve either selective or uniform irradiation of the wall defining the body lumen.
  • the radiation transmission means having an emitting portion on its distal end is slidabl ⁇ disposed within an inner lumen of the elongated shaft so that the emitting portion generally resides within the inflatable member.
  • the system is configured so that the emitting portion may travel at least along the length of the inflatable member by longitudinally moving the transmission means within the inner lumen.
  • the emitting portion may be configured to transmit radiation in a particular radial direction and the transmission means may be configured to also rotate within the lumen.
  • the emitting portion may comprise the cut end of the transmission means so that radiation is emitted in a cone.
  • One advantage of this design is a minimized outer diameter. Accordingly, such transmission means may be incorporated into balloon angioplasty catheter while maintaining an overall low system profile.
  • FIG. 1 is a longitudinal elevational view, partially in section, of a photodynamic therapy system of this invention.
  • FIG. 2 is an elevational view of an emitting portion of a radiation transmission means configured to emit radiation in a biased radial direction.
  • FIG. 1 illustrates a photodynamic therapy system 10 embodying features of the invention which generally include an elongated flexible shaft 11 having a guide wire lumen 12, an inflation lumen 13, a radiation transmission means lumen 14 and an inflatable member 15 on a distal
  • a guidewire 17 is slidabl ⁇ disposed within guidewire lumen 12.
  • a radiation transmission means 18 having emitting portion 19 on the distal end is slidably disposed within lumen 14. Emitting portion 19 may travel longitudinally through the portion of lumen 14 which resides within inflatable member 15.
  • the proximal portion of radiation transmission means 18 extends out the adaptor 16 and is operatively connected to a radiation generating means (not shown).
  • a radiation generating means for generating UVA radiation, an argon laser is suitable.
  • Radiation transmission means 18 generally comprises a conventional optical fiber having low attenuation for the wavelength of the radiation to be transmitted, but other wave guides may be suitable. Photoactivation typically requires energy delivery only on the order of
  • a single fiber usually has sufficient diameter to transmit the requisite energy while maintaining flexibility to traverse tortuous regions of the body lumen.
  • emitting portion 19 is formed by simply
  • Fibers suitable for transmitting ultraviolet wavelength having a numerical aperture of 0.37 and a
  • the emitting portion 19 could comprise a lens or other
  • FIG. 2 illustrates the emitting portion 19 of radiation transmission means 18 in which a bare portion of an optical fiber has been cut at a 45° angle and the cut end has been mirrored.
  • transmission means 18 should be rotatably disposed within lumen 14 to allow the axial rotation of emitting portion
  • the wall defining the body lumen adjacent inflatable member 15 may be selectively or uniformly irradiated.
  • inflatable member 15 is configured to displace blood to allow transmission of radiation from the emitting portion 19 to the wall defining the body lumen adjacent the inflatable member 15.
  • Inflatable member 15 should be relatively transparent to the wavelength of the radiation used, but otherwise may be formed in a conventional manner. Inflatable member 15 may further comprise perfusion ports and lumens in a conventional manner to allow treatment without causing downstream ischemic conditions.
  • inflation member 15 is configured to carry out an angioplasty procedure. This allows dilatation and subsequent irradiation to be performed without introducing separate devices. However, it may be desirable to configure inflatable member 15 to displace blood only, requiring only low pressure inflation and allowing the use of materials having optimal transmission characteristics. In these embodiments, a separate angioplasty balloon could be carried on another portion of the elongated shaft 11 to allow both procedures to be performed using the same device.
  • the system 10 may be located by first introducing a guiding catheter (not shown).
  • a guidewire 17 is backloaded into guidewire receiving lumen 13, and both the guidewire and the system 10 are advanced together through the guiding catheter to its distal end.
  • the guidewire 17 is advanced out the guiding catheter through the patient's vasculature via fluoroscopic imaging until it crosses the target area.
  • the system 10 is advanced over the guidewire 17 until the inflatable member 15 is positioned across the area.
  • the inflatable member 15 is inflated to displace blood and facilitate transmission of radiation.
  • Emitting portion 19 is disposed within lumen 14 just distal of inflatable member 15. Radiation is then supplied
  • the controlled pull may be achieved by a control means 20.
  • a control means 20 For example, a stepper motor may be operatively connected to transmission means 18, but other means are also suitable.
  • System 10 may be used in any application to deliver radiation of a desired wavelength to a region within a patient's vasculature.
  • this may include the activation of any photoactivatable agent, including porphyrins, phthalocyanine compounds and psoralens.
  • System 10 has been shown to be effective in inhibiting smooth muscle cell proliferation following angioplasty in rabbits (Spaedy, TJ et al.,
  • Photoactivation of psoralens generally requires radiation having a wavelength between about 320 nm and 400 nm. Other photoactivabie agents require wavelengths specific to the agent. Concerns about UV toxicity in particular may make longer wavelengths desirable. In particular, wavelengths between 400 nm and 900 nm, corresponding to laser diode activation, may also be used.

Abstract

A method and catheter system for irradiating a body lumen wall which comprises providing an elongated, flexible radiation transmission member having an emitting portion at its distal end, advancing the emitting portion to an area adjacent the wall defining the patient's body lumen to be treated by irradiation, and directing radiation through the transmission member while moving the transmission member to cause the emitting portion to irradiate a length of the wall of the body lumen. The transmission member may be rotated independently or in conjunction with longitudinal movement to achieve either selective or uniform irradiation of the wall defining the body lumen. In one embodiment, this invention comprises an elongated flexible shaft, having an inflatable member disposed at the distal end. A radiation transmission member having an emitting portion on its distal end is slidably disposed within the elongated shaft so that the emitting portion resides within the inflatable member. The system is configured so that the emitting portion may travel at least along the length of the inflatable member by longitudinally moving the transmission member. Optionally, the emitting portion may be configured to transmit radiation in a particular radial direction and the transmission member may be configured to rotate axially within the lumen.

Description

PHOTODYNAMIC THERAPY SYSTEM AND METHOD
BACKGROUND OF THE INVENTION
This invention is directed to the treatment of blood vessels affected
by arteriosclerosis and more particularly to an assembly and method for preventing the restenosis of vessels following angioplasty comprising
treating the vessel with a photoactivatable agent and selectively irradiating the treated area.
Arteriosclerosis is a common condition which occurs when atheromas, fatty-like substances, deposit in the blood vessels of a patient. Stenoses resulting from such deposits can seriously interfere with blood flow in the affected vessel, creating ischemic conditions distal to the stenosis. Balloon angioplasty procedures are a well known means for recanalizing stenosed vessels but currently suffer from a high rate of
restenosis, requiring additional angioplasty or resort to other treatments such as atherectomy. Further, restenosis is also associated with these other means of treating arteriosclerosis.
Proliferation of smooth muscle cells resulting from the trauma to the vessel wall is thought to be a major factor in causing restenosis. Accordingly, many attempts to reduce restenosis have centered around
inhibiting the growth of smooth muscle cells. United States Patent No. 5,116,864 (March et al.), which is incorporated in its entirety by reference, discloses one promising technique. This reference teaches the use of photoactivatable psoralens to significantly inhibit the proliferation of smooth muscle cells following irradiation with long-wave ultraviolet light. In general, psoralen is administered to the patient orally, intravenously or via drug-delivery catheters such as disclosed in United States Patent Application Serial No. 08/238,904, filed May 6, 1994, which are incorporated in their entirety by reference. Next, the stenosed area of the patient's vasculature is recanalized by angioplasty, atherectomy or other procedure. Finally, a catheter carrying an optical
fiber is used to irradiate the recanalized area of the patient's vasculature with UV radiation having a wavelength of approximately 320 to 400 nm.
For this procedure to be effective, the irradiation of the recanalized area must effectively activate the psoralen. Accordingly, the catheter system used should provide either relatively uniform irradiation or selective irradiation as desired by the operator. United States Patent No. 4,773,899 (Spears), which is incorporated in its entirety by reference, represents an example of a balloon catheter for delivering UV radiation in conjunction with photodynamic therapy. However, there are a number of drawbacks associated with the Spears catheter. The reference discloses only the simultaneous irradiation of all parts of the wall adjacent to the balloon. Achieving simultaneous, uniform irradiation is technically difficult. It often requires a complex interface at the distal end of the fiber to provide uniform diffusion of the emitted radiation. Generally, the means for diffusing radiation at the end of the fiber increases the diameter of the optical fiber and correspondingly increases the overall outer diameter of the system. Alternatively, the means for diffusing radiation involves removing the protective sheath and cladding from a distal portion of the optical fiber, making the fiber susceptible to breakage. There also may be conditions which make it desirable to selectively irradiate the vessel, for example, when there is an asymmetric lesion. The Spears catheter and the other prior art devices do not offer this capability.
What has been needed is a simple catheter system and method for either uniformly or selectively supplying an effective amount of radiation
to activate administered psoralen or other photoactivatable therapeutic agents which is easy to manufacture. There is also a need for a radiation
transmission and emitting means which has a small profile. This invention satisfies these and other needs.
SUMMARY OF THE INVENTION
This invention provides a method for treating a wall defining a patient's body lumen by irradiation comprising the steps of providing an elongated, flexible radiation transmission means having an emitting portion at its distal end, advancing the radiation transmission means within the patient's body lumen until the emitting portion is adjacent an area of the wall defining the body lumen to be treated by irradiation, and directing radiation through the transmission means while moving the transmission means to cause the emitting portion to irradiate a length of the wall of the body lumen. In a Dreferred embodiment, the radiation transmission means is moved longitudinally within the body lumen. If desired, the emitting portion of the transmission means may be configured to bias the radiation in a particular radial direction. When using a transmission means having this feature, the transmission means may be rotated independently or in conjunction with longitudinal movement to achieve either selective or uniform irradiation of the wall defining the body lumen.
One embodiment of a device useful in the practice of this invention comprises an elongated flexible shaft having an inflatable member
disposed at the distal end. The radiation transmission means having an emitting portion on its distal end is slidablγ disposed within an inner lumen of the elongated shaft so that the emitting portion generally resides within the inflatable member. The system is configured so that the emitting portion may travel at least along the length of the inflatable member by longitudinally moving the transmission means within the inner lumen. Optionally, the emitting portion may be configured to transmit radiation in a particular radial direction and the transmission means may be configured to also rotate within the lumen. Preferably, the emitting portion may comprise the cut end of the transmission means so that radiation is emitted in a cone. One advantage of this design is a minimized outer diameter. Accordingly, such transmission means may be incorporated into balloon angioplasty catheter while maintaining an overall low system profile. BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a longitudinal elevational view, partially in section, of a photodynamic therapy system of this invention.
FIG. 2 is an elevational view of an emitting portion of a radiation transmission means configured to emit radiation in a biased radial direction.
DETAILED DESCRIPTION OF THE DRAWINGS
FIG. 1 illustrates a photodynamic therapy system 10 embodying features of the invention which generally include an elongated flexible shaft 11 having a guide wire lumen 12, an inflation lumen 13, a radiation transmission means lumen 14 and an inflatable member 15 on a distal
portion of shaft 11 in fluid communication through the inflation lumen 13 with an adaptor 16 at the proximal end of shaft 11. A guidewire 17 is slidablγ disposed within guidewire lumen 12. A radiation transmission means 18 having emitting portion 19 on the distal end is slidably disposed within lumen 14. Emitting portion 19 may travel longitudinally through the portion of lumen 14 which resides within inflatable member 15. The proximal portion of radiation transmission means 18 extends out the adaptor 16 and is operatively connected to a radiation generating means (not shown). For generating UVA radiation, an argon laser is suitable.
The system is configured so that appropriate longitudinal movement of radiation transmission means 18 causes emitting portion 19 to travel the length of balloon member 15. Radiation transmission means 18 generally comprises a conventional optical fiber having low attenuation for the wavelength of the radiation to be transmitted, but other wave guides may be suitable. Photoactivation typically requires energy delivery only on the order of
milliwatts, so a single fiber usually has sufficient diameter to transmit the requisite energy while maintaining flexibility to traverse tortuous regions of the body lumen.
In a preferred embodiment, emitting portion 19 is formed by simply
cutting the optical fiber. In such embodiments, it is desirable to maximize the numerical aperture of the fiber so that radiation is emitted in a cone
having an apex as large as practical. Fibers suitable for transmitting ultraviolet wavelength having a numerical aperture of 0.37 and a
corresponding emission cone of approximately 43°are available. Shorter fiber lengths may enable higher numerical apertures. The emitted radiation is further scattered by the lumen 14 and the inflatable member
15. Alternatively, the emitting portion 19 could comprise a lens or other
means for diffusing light or could comprise a treated portion of transmission means 18, for example an abraded or deciaded portion. Treating the transmission member can weaken the treated portion and generally increases the manufacturing difficulties. On the other hand, such treatment can cause the emitting portion to transmit a greater proportion of the radiation in a lateral direction towards the wall of the body lumen or to transmit the radiation in a particular radial direction. FIG. 2 illustrates the emitting portion 19 of radiation transmission means 18 in which a bare portion of an optical fiber has been cut at a 45° angle and the cut end has been mirrored.
These features in conjunction with longitudinal movement of the transmission means allow increased control over dosimetry. For example, the embodiment shown in FIG. 2 transmits radiation in a biased radial direction. Preferably, transmission means 18 should be rotatably disposed within lumen 14 to allow the axial rotation of emitting portion
19 within inflatable member 15. Thus, by appropriate rotation and/or
longitudinal movement of the radiation transmission means 18, the wall defining the body lumen adjacent inflatable member 15 may be selectively or uniformly irradiated.
Generally, inflatable member 15 is configured to displace blood to allow transmission of radiation from the emitting portion 19 to the wall defining the body lumen adjacent the inflatable member 15. Inflatable member 15 should be relatively transparent to the wavelength of the radiation used, but otherwise may be formed in a conventional manner. Inflatable member 15 may further comprise perfusion ports and lumens in a conventional manner to allow treatment without causing downstream ischemic conditions. In some embodiments, inflation member 15 is configured to carry out an angioplasty procedure. This allows dilatation and subsequent irradiation to be performed without introducing separate devices. However, it may be desirable to configure inflatable member 15 to displace blood only, requiring only low pressure inflation and allowing the use of materials having optimal transmission characteristics. In these embodiments, a separate angioplasty balloon could be carried on another portion of the elongated shaft 11 to allow both procedures to be performed using the same device.
The method of using the photodynamic therapy systems of this invention generally follows conventional practices. In particular, the system 10 may be located by first introducing a guiding catheter (not
shown) having a preshaped distal tip percutaneouslγ in the patient's arterial system using the conventional Seldinger technique and advancing
it until the preshaped distal tip is seated in the ostium of the desired artery. A guidewire 17 is backloaded into guidewire receiving lumen 13, and both the guidewire and the system 10 are advanced together through the guiding catheter to its distal end. The guidewire 17 is advanced out the guiding catheter through the patient's vasculature via fluoroscopic imaging until it crosses the target area. Then the system 10 is advanced over the guidewire 17 until the inflatable member 15 is positioned across the area. The inflatable member 15 is inflated to displace blood and facilitate transmission of radiation. Emitting portion 19 is disposed within lumen 14 just distal of inflatable member 15. Radiation is then supplied
through radiation transmission means 18 while transmission means 18 is pulled back through lumen 14 at a controlled rate. The controlled pull may be achieved by a control means 20. For example, a stepper motor may be operatively connected to transmission means 18, but other means are also suitable. Once emitting portion 19 has traveled to an area of lumen 14 proximal to inflatable member 15, a uniform dose of radiation has been supplied to the tissue adjacent the inflatable member 15.
System 10 may be used in any application to deliver radiation of a desired wavelength to a region within a patient's vasculature. In particular, this may include the activation of any photoactivatable agent, including porphyrins, phthalocyanine compounds and psoralens. System 10 has been shown to be effective in inhibiting smooth muscle cell proliferation following angioplasty in rabbits (Spaedy, TJ et al.,
unpublished manuscript). Rabbits given a systemic administration of 8- methoxypsoralen to a serum level of about 1 μM followed by irradiation with 10 J/cm2 of 351 nm UVA in conjunction with angioplasty demonstrated inhibition of smooth muscle proliferation compared to
rabbits undergoing angioplasty alone, angioplasty followed by irradiation or angioplasty followed by systemic administration of psoralen. Photoactivation of psoralens generally requires radiation having a wavelength between about 320 nm and 400 nm. Other photoactivabie agents require wavelengths specific to the agent. Concerns about UV toxicity in particular may make longer wavelengths desirable. In particular, wavelengths between 400 nm and 900 nm, corresponding to laser diode activation, may also be used.
Although it has been described primarily with reference to presently preferred embodiments, one skilled in the art should recognize that various modifications and improvements are within the scope of this invention.

Claims

What is claimed is:
1. A method for treating a wall defining a patient's body lumen by irradiation, comprising: a) providing an elongated radiation transmission means having an emitting portion on the distal tip which is configured to emit a substantial amount of radiation in a lateral direction toward the wall defining the body lumen to be treated;
b) advancing the radiation transmission means through the patient's body lumen to a location therein for irradiation
therapy; c) directing radiation through the radiation transmission means and emitting radiation passing through the radiation transmission means through the emitting portion with a substantial amount of the emitted radiation being directed to and impinging on the wall defining the body lumen; and d) moving the radiation transmission means within the patient's lumen as radiation is emitted from the emitting portion to irradiate the wall defining the body lumen.
2. The method of claim 1 further comprising the step of moving the radiation transmission means longitudinally within the patient's lumen as radiation is emitted from the emitting portion to irradiate a length of
the wall defining the body lumen.
3. The method of claim 1 further comprising the step of rotating the radiation transmission means within the patient's lumen as radiation is emitted from the emitting portion to irradiate a length of the wall defining the body lumen.
4. The method of claim 2 wherein a control means is operatively connected to the radiation transmission means, further comprising the step of moving the transmission means at a controlled
rate.
5. The method of claim 1 further comprising the step of
administering a photoactivatable agent to the wall of the body lumen prior to irradiation.
6. The method of claim 5 wherein the photoactivatable agent comprises a psoralen, further comprising the step of directing radiation having a wavelength between about 320 nm and about 400 nm through the radiation transmission means.
7. The method of claim 5 further comprising the step of directing laser diode radiation having a wavelength between about 400 nm and about 900 nm through the radiation transmission means.
8. A method for treating a wall defining a patient's body lumen by irradiation, comprising: a) providing an elongated flexible shaft having an inflation lumen, a radiation transmission means lumen, an inflatable
member on a distal portion of the shaft in fluid communication with the inflation lumen and a radiation transmission means having emitting portion slidably disposed within the radiation transmission means lumen;
b) advancing the elongated flexible shaft through the patient's body lumen to a location therein for irradiation therapy; c) directing radiation through the radiation transmission means and emitting radiation passing through the radiation transmission means through the emitting portion with a substantial amount of the emitted radiation being directed to and impinging on the wall defining the body lumen; and d) moving the radiation transmission means within the patient's lumen as radiation is emitted from the emitting portion to irradiate a length of the wall defining the body lumen.
9. The method of claim 8 further comprising the step of moving
the radiation transmission means longitudinally within the patient's lumen as radiation is emitted from the emitting portion to irradiate a length of the wall defining the body lumen.
10. The method of claim 8 further comprising the step of rotating the radiation transmission means within the patient's lumen as radiation is emitted from the emitting portion to irradiate a length of the wall defining the body lumen.
1 1. The method of claim 9 wherein a control means is operatively connected to the radiation transmission means to move the transmission means at a controlled rate.
12. The method of claim 8 further comprising the step of administering a photoactivatable agent to the wall of the body lumen prior to irradiation.
13. The method of claim 12 wherein the photoactivatable agent comprises a psoralen, further comprising the step of directing radiation having a wavelength between about 320 nm and about 400 nm through the radiation transmission means.
14. The method of claim 8 wherein the inflatable member is configured to perform an angioplasty procedure, further comprising the step of inflating the inflatable member to dilate the patient's body lumen.
15. A photodynamic therapy system for treating a wall defining a patient's body lumen by irradiation, comprising: a) an elongated flexible shaft having an inner lumen; b) a radiation transmission means having a distal end slidably and rotatably disposed within the inner lumen; and c) an emitting portion on the distal portion of the radiation transmission means capable of longitudinal and rotational movement within the inner lumen.
16. The system of claim 15 wherein the radiation transmission
means comprises an optical fiber.
17. The system of claim 16 wherein the emitting portion emits a cone of radiation having an apex of at least 40° .
18. The system of claim 16 wherein the emitting portion emits a cone of radiation having an apex of at least 60°.
19. The system of claim 15 wherein the emitting portion is configured to emit radiation in a biased radial direction.
20. The system of claim 15, wherein the elongated flexible shaft has an inflation lumen and an inflatable member on a distal portion of the shaft in fluid communication with the inflation lumen.
PCT/US1996/004252 1995-03-28 1996-03-27 Photodynamic therapy system and method WO1996029943A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41214395A 1995-03-28 1995-03-28
US08/412,143 1995-03-28

Publications (1)

Publication Number Publication Date
WO1996029943A1 true WO1996029943A1 (en) 1996-10-03

Family

ID=23631764

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/004252 WO1996029943A1 (en) 1995-03-28 1996-03-27 Photodynamic therapy system and method

Country Status (2)

Country Link
US (1) US6132423A (en)
WO (1) WO1996029943A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855546A (en) * 1996-02-29 1999-01-05 Sci-Med Life Systems Perfusion balloon and radioactive wire delivery system
US5873811A (en) * 1997-01-10 1999-02-23 Sci-Med Life Systems Composition containing a radioactive component for treatment of vessel wall
US5951458A (en) * 1996-02-29 1999-09-14 Scimed Life Systems, Inc. Local application of oxidizing agents to prevent restenosis
EP1648562A2 (en) * 2003-07-09 2006-04-26 Light Sciences Corporation Device for distal protection and treatment of blood vessels
US7730894B2 (en) 2003-03-14 2010-06-08 Light Sciences Oncology, Inc. Photodynamic therapy apparatus and method for vascular tissue treatment
JP2015097780A (en) * 2013-10-15 2015-05-28 ニプロ株式会社 Ablation system and ablation device
JP2015217215A (en) * 2014-05-20 2015-12-07 ニプロ株式会社 Ablation device and ablation system
EP3135110A1 (en) 2015-08-26 2017-03-01 Universitätsklinikum Regensburg 1,7-diaryl-1,6-heptadien-3,5-dion derivatives, methods of making and using the same
EP3225112A1 (en) 2016-04-01 2017-10-04 Universitätsklinikum Regensburg Photosensitiser dispersion and use of the same
US10307610B2 (en) 2006-01-18 2019-06-04 Light Sciences Oncology Inc. Method and apparatus for light-activated drug therapy
US10376711B2 (en) 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0686342B1 (en) 1994-06-10 1998-09-09 Schneider (Europe) GmbH A medical appliance for the treatment of a portion of body vessel by ionising radiation
EP0965363B1 (en) 1994-06-24 2002-02-13 Schneider (Europe) GmbH Medical appliance for the treatment of a portion of body vessel by ionizing radiation
US6234951B1 (en) 1996-02-29 2001-05-22 Scimed Life Systems, Inc. Intravascular radiation delivery system
DE19954710C1 (en) * 1999-11-17 2001-03-15 Pulsion Medical Sys Ag Apparatus for treatment of blood vessels especially in eye, comprises laser to deliver structured beam and monitor system to measure concentration of chromophoric agents for system control
US6692486B2 (en) * 2000-05-10 2004-02-17 Minnesota Medical Physics, Llc Apparatus and method for treatment of cerebral aneurysms, arterial-vascular malformations and arterial fistulas
US6887862B2 (en) 2001-05-31 2005-05-03 Miravant Systems, Inc. Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
EP1314451B1 (en) * 2001-11-23 2009-07-01 Nucletron B.V. Device for effecting radiation therapy in an animal body
US6984229B2 (en) * 2002-03-21 2006-01-10 Ceramoptec Industries, Inc. Device and method for minimizing restenosis after angioplasty treatment
WO2004012589A2 (en) * 2002-08-05 2004-02-12 Miravant Medical Technologies, Inc. Catheter for diagnosis and treatment of diseased vessels
AU2003258124A1 (en) 2002-08-05 2004-02-23 Miravant Medical Technologies Light delivery catheter
US20040236275A1 (en) * 2003-05-20 2004-11-25 Pruitt Sean R. Catheter having a light emitting component
US20080077225A1 (en) * 2006-09-22 2008-03-27 Carlin Donald B Accuracy lumen sizing and stent expansion
US20090171332A1 (en) * 2007-12-27 2009-07-02 Intuitive Surgical, Inc. Medical device with orientable tip for robotically directed laser cutting and biomaterial application
US9693826B2 (en) * 2008-02-28 2017-07-04 Biolitec Unternehmensbeteiligungs Ii Ag Endoluminal laser ablation device and method for treating veins
US10201387B2 (en) 2013-03-13 2019-02-12 The Spectranetics Corporation Laser-induced fluid filled balloon catheter
US10842567B2 (en) 2013-03-13 2020-11-24 The Spectranetics Corporation Laser-induced fluid filled balloon catheter
US9320530B2 (en) 2013-03-13 2016-04-26 The Spectranetics Corporation Assisted cutting balloon
AU2014285081A1 (en) * 2013-07-03 2016-02-25 Uvlrx Therapeutics Inc. Sheathed optical fiber
US11246659B2 (en) 2014-08-25 2022-02-15 The Spectranetics Corporation Liquid laser-induced pressure wave emitting catheter sheath
US11058492B2 (en) 2014-12-30 2021-07-13 The Spectranetics Corporation Laser-induced pressure wave emitting catheter sheath
US10898213B2 (en) 2014-12-30 2021-01-26 The Spectranetics Corporation Electrically-induced pressure wave emitting catheter sheath
EP3240603B1 (en) 2014-12-30 2019-05-01 The Spectranetics Corporation Laser-induced fluid filled balloon catheter

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0311295A2 (en) * 1987-10-07 1989-04-12 University College London Improvements in surgical apparatus
WO1992017243A2 (en) * 1991-04-05 1992-10-15 Indigo Medical, Incorporated Apparatus using a laser lucent needle
US5320617A (en) * 1993-06-25 1994-06-14 Leach Gary E Method of laser-assisted prostatectomy and apparatus for carrying out the method
US5419777A (en) * 1994-03-10 1995-05-30 Bavaria Medizin Technologie Gmbh Catheter for injecting a fluid or medicine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4773899A (en) * 1982-11-23 1988-09-27 The Beth Israel Hospital Association Method of treatment of artherosclerosis and balloon catheter the same
US5019075A (en) * 1984-10-24 1991-05-28 The Beth Israel Hospital Method and apparatus for angioplasty
US5346488A (en) * 1985-04-08 1994-09-13 The General Hospital Corporation Laser-induced ablation of atherosclerotic plaque
US4860743A (en) * 1986-10-27 1989-08-29 University Of Florida Laser method and apparatus for the recanalization of vessels and the treatment of other cardiac conditions
US5269779A (en) * 1988-06-06 1993-12-14 Sumitomo Electric Industries, Ltd. Laser beam guiding fiber assembly
DE3941705C2 (en) * 1989-12-18 1994-10-13 Gsf Forschungszentrum Umwelt Device for the isotropic irradiation of cavities of spherical shape
US5188634A (en) * 1990-07-13 1993-02-23 Trimedyne, Inc. Rotatable laser probe with beveled tip
US5053033A (en) * 1990-10-10 1991-10-01 Boston Advanced Technologies, Inc. Inhibition of restenosis by ultraviolet radiation
US5435307A (en) * 1991-03-29 1995-07-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Surface fluorescent monitor
US5116864A (en) * 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
US5302168A (en) * 1991-09-05 1994-04-12 Hess Robert L Method and apparatus for restenosis treatment
US5222953A (en) * 1991-10-02 1993-06-29 Kambiz Dowlatshahi Apparatus for interstitial laser therapy having an improved temperature sensor for tissue being treated
US5437660A (en) * 1991-12-30 1995-08-01 Trimedyne, Inc. Tissue ablation and a lateral-lasing fiber optic device therefor
US5417653A (en) * 1993-01-21 1995-05-23 Sahota; Harvinder Method for minimizing restenosis
US5366456A (en) * 1993-02-08 1994-11-22 Xintec Corporation Angle firing fiber optic laser scalpel and method of use
US5464404A (en) * 1993-09-20 1995-11-07 Abela Laser Systems, Inc. Cardiac ablation catheters and method
US5487740A (en) * 1994-03-02 1996-01-30 Energy Life Systems Corporation Laser device for ablation of human tissue
US5776174A (en) * 1995-01-30 1998-07-07 Illumenex Corporation Stabilization of vascular lesions by ultraviolet radiation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0311295A2 (en) * 1987-10-07 1989-04-12 University College London Improvements in surgical apparatus
WO1992017243A2 (en) * 1991-04-05 1992-10-15 Indigo Medical, Incorporated Apparatus using a laser lucent needle
US5320617A (en) * 1993-06-25 1994-06-14 Leach Gary E Method of laser-assisted prostatectomy and apparatus for carrying out the method
US5419777A (en) * 1994-03-10 1995-05-30 Bavaria Medizin Technologie Gmbh Catheter for injecting a fluid or medicine

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5951458A (en) * 1996-02-29 1999-09-14 Scimed Life Systems, Inc. Local application of oxidizing agents to prevent restenosis
US5855546A (en) * 1996-02-29 1999-01-05 Sci-Med Life Systems Perfusion balloon and radioactive wire delivery system
US5873811A (en) * 1997-01-10 1999-02-23 Sci-Med Life Systems Composition containing a radioactive component for treatment of vessel wall
US7730894B2 (en) 2003-03-14 2010-06-08 Light Sciences Oncology, Inc. Photodynamic therapy apparatus and method for vascular tissue treatment
US10376711B2 (en) 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
EP1648562A2 (en) * 2003-07-09 2006-04-26 Light Sciences Corporation Device for distal protection and treatment of blood vessels
JP2007528752A (en) * 2003-07-09 2007-10-18 ライト サイエンシズ オンコロジー， インコーポレイテッド Peripheral protection and treatment device for blood
EP1648562A4 (en) * 2003-07-09 2009-03-25 Light Sciences Oncology Inc Device for distal protection and treatment of blood vessels
JP4746542B2 (en) * 2003-07-09 2011-08-10 ライト、サイエンシーズ、オンコロジー、インコーポレイテッド Peripheral protection and treatment device for blood
US10307610B2 (en) 2006-01-18 2019-06-04 Light Sciences Oncology Inc. Method and apparatus for light-activated drug therapy
JP2015097780A (en) * 2013-10-15 2015-05-28 ニプロ株式会社 Ablation system and ablation device
JP2015217215A (en) * 2014-05-20 2015-12-07 ニプロ株式会社 Ablation device and ablation system
WO2017032892A1 (en) 2015-08-26 2017-03-02 Universitätsklinikum Regensburg 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the prodcution and use thereof
EP3135110A1 (en) 2015-08-26 2017-03-01 Universitätsklinikum Regensburg 1,7-diaryl-1,6-heptadien-3,5-dion derivatives, methods of making and using the same
US11191855B2 (en) 2015-08-26 2021-12-07 Universitätsklinikum Regensburg 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof
US11938233B2 (en) 2015-08-26 2024-03-26 Universitätsklinikum Regensburg 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof
EP3225112A1 (en) 2016-04-01 2017-10-04 Universitätsklinikum Regensburg Photosensitiser dispersion and use of the same
WO2017167992A1 (en) 2016-04-01 2017-10-05 Universität Regensburg Photosensitive dispersion and use thereof

Also Published As

Publication number Publication date
US6132423A (en) 2000-10-17

Similar Documents

Publication Publication Date Title
US6132423A (en) Photodynamic therapy system and method
AU698703B2 (en) Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis
US5607419A (en) Method and apparatus for treating vessel wall with UV radiation following angioplasty
US7396354B2 (en) Light delivery catheter
US6520957B1 (en) Treatment of in-stent restenosis using cytotoxic radiation
US5417653A (en) Method for minimizing restenosis
US5700243A (en) Balloon perfusion catheter
US6398708B1 (en) Perfusion balloon and radioactive wire delivery system
AU722118B2 (en) Improved phototherapeutic methods and devices for irradiating columnar environments
EP0542901B1 (en) Fiber optic laser catheter
AU720161B2 (en) Balloon catheter for photodynamic therapy
JP2005534409A (en) Light transmission catheter
US20070088317A1 (en) Catheters and methods of using catheters
WO1999029370A1 (en) Catheter system having tubular radiation source
JP4421300B2 (en) Apparatus and method for minimizing restenosis after angioplasty treatment
US7214223B2 (en) Photoatherolytic catheter apparatus and method
JP2007528754A (en) Light generator that automatically aligns in the lumen for photodynamic therapy
JPH07132146A (en) Catheter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase